Organization
Baili-Bio (Chengdu) Pharmaceutical Co., Ltd., Chengdu, China
2 abstracts
Abstract
GNC-038, a tetra-specific antibody, in patients with R/R non-Hodgkin lymphoma or acute lymphoblastic leukemia: A phase 1 study design and rationale.Org: Institute of Hematology, Chinese Academy of Medical Sciences, Tianjin, China, Blood Institute of the Chinese Academy of Medical Sciences, Tianjin, China, Department of Lymphoma, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China, Anhui Medical University Second Affiliated Hospital, Anhui, China, School of Medicine, Tongji Hospital of Tongji University, Shanghai, China,
Abstract
SI-B003 (PD-1/CTLA-4) in patients with advanced solid tumors: A phase I study.Org: Department of Early Drug Development Center, Peking University Cancer Hospital & Institute, Beijing, China, Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, China, Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China, Henan Cancer Hospital, Zhengzhou, China, Shanghai General Hospital, Shanghai, China,